EUCROF has a new executive board
Following elections at last week’s General Assembly in Munich, EUCROF is very pleased to announce the new Executive Board members for the next two years.
Dr. Martine Dehlinger-Kremer was elected to the position of President replacing Dr. Stefano Marini, who could not stand again having served the permitted three mandates as President. Dr. Stefano Marini was elected as Vice-President and will continue to be actively involved with the Executive Board. Yoani Matsakis and Christophe Golenvaux were both re-elected to the Executive Board as Treasurer and Board Member respectively. Simon Lee was elected for the first time to the position of Secretary. The new Executive Board with immediate effect is thus as follows:-
Dr. Martine Dehlinger-Kremer – President
Dr. Stefano Marini – Vice-President
Simon Lee – Secretary
Yoani Matsakis – Treasurer
Christophe Golenvaux – Member
The Executive Board on behalf of EUCROF’s members wish to thank Darina Hrdlickova who has been a member of the EUCROF Board in the position of Secretary since 2012. Darina’s support of the EUCROF conference in Prague has been key to its success.
These elections were significant in that they saw the end of a long association of Dagmar Chase who was one of the founding members of EUCROF. Dagmar took the decision to step down as Vice-President and no longer stand for an Executive Board position after serving the Board for 11 years. The Executive Board on behalf of EUCROF’s members wish to extend its sincere thanks to Dagmar for her unwavering commitment toward the EUCROF cause and her many achievements during her tenure. However, we are pleased that Dagmar will continue to be involved in EUCROF activities including Chair of the Clinical Trial Legislation Working Group.
Finally our sincere thanks also goes to Stefano Marini who participated to the founding of EUCROF in 2005 and led EUCROF as President for the last 6 years and, together with Dagmar Chase, has successfully established EUCROF into one of the leading associations of its type in Europe, recognised by key stakeholders in the Pharmaceutical Industry, as well as by Regulatory Authorities.
“I am honored to be entrusted by EUCROF members with this election as President,” said Dehlinger-Kremer. “I look forward to working with the board to further the Federation’s vision as a key institution in contributing to the development of better medicines for patients through CRO knowledge and expertise. We will collaborate with authorities, partner with pharma and patient associations, and expand the training role for CROs to further EUCROF’s mission.”
“I am glad that Martine Dehlinger-Kremer has been elected as new EUCROF President as I am sure she will act with the needed passion and competence and wish all possible success to the new Executive Board” said Marini.
For further information please contact the Secretary and/or President via email on